• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高弗吉尼亚州人乳头瘤病毒疫苗接种率的障碍与促进因素:一项对儿科护士有启示意义的利益相关者分析

Barriers and Facilitators to Improving Virginia's HPV Vaccination Rate: A Stakeholder Analysis With Implications for Pediatric Nurses.

作者信息

Carhart Miev Y, Schminkey Donna L, Mitchell Emma M, Keim-Malpass Jessica

机构信息

University of Virginia School of Nursing, Charlottesville, VA, USA.

University of Virginia School of Nursing, Charlottesville, VA, USA; University of Virginia School of Medicine, Department of Pediatrics, Charlottesville, VA, USA.

出版信息

J Pediatr Nurs. 2018 Sep-Oct;42:1-8. doi: 10.1016/j.pedn.2018.05.008. Epub 2018 May 24.

DOI:10.1016/j.pedn.2018.05.008
PMID:30219293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6140351/
Abstract

PURPOSE

Despite the evidence, the availability since 2006, and strong recommendations from many professional organizations, the human papillomavirus (HPV) vaccine has had a low uptake rate nationally and these trends have been even lower in the state of Virginia.

DESIGN AND METHODS

We explored key stakeholders' perspectives on factors influencing HPV vaccination in central and southern Virginia organized within the socio-ecological model (SEM) framework. We conducted semi-structured key informant interviews with 31 stakeholders involved in HPV vaccination or cancer prevention.

RESULTS

Stakeholders identified barriers at all SEM levels: Knowledge gaps and sexuality concerns (parent-child dyad level), time constraint and inconsistent recommendation (interpersonal level), lack of leadership and informational support (organizational and community level), and an ineffective mandate (policy level). Facilitators identified were realistic/receptive attitude (parent-child dyad level), provider's strong recommendation and educational support (interpersonal level), team approach and useful data (organizational level), educational outreach and community resources (community level), and support from federal and professional organizations (policy level).

CONCLUSIONS

The stakeholder analysis provided an environmental scan of the barriers and facilitators so that an effective HPV vaccination strategy can be planned and implemented in the Commonwealth of Virginia by public health nurses.

摘要

目的

尽管有相关证据,自2006年起就可获得该疫苗,且许多专业组织也大力推荐,但人乳头瘤病毒(HPV)疫苗在全国的接种率较低,在弗吉尼亚州这种趋势更为明显。

设计与方法

我们在社会生态模型(SEM)框架内,探讨了弗吉尼亚州中部和南部关键利益相关者对影响HPV疫苗接种因素的看法。我们对31名参与HPV疫苗接种或癌症预防的利益相关者进行了半结构化关键信息人访谈。

结果

利益相关者在SEM的各个层面都识别出了障碍:知识差距和对性方面的担忧(亲子二元组层面)、时间限制和建议不一致(人际层面)、缺乏领导力和信息支持(组织和社区层面)以及指令无效(政策层面)。识别出的促进因素包括现实/接受态度(亲子二元组层面)、提供者的强烈推荐和教育支持(人际层面)、团队协作方法和有用数据(组织层面)、教育推广和社区资源(社区层面)以及来自联邦和专业组织的支持(政策层面)。

结论

利益相关者分析对障碍和促进因素进行了环境审视,以便公共卫生护士能够在弗吉尼亚州规划并实施有效的HPV疫苗接种策略。

相似文献

1
Barriers and Facilitators to Improving Virginia's HPV Vaccination Rate: A Stakeholder Analysis With Implications for Pediatric Nurses.提高弗吉尼亚州人乳头瘤病毒疫苗接种率的障碍与促进因素:一项对儿科护士有启示意义的利益相关者分析
J Pediatr Nurs. 2018 Sep-Oct;42:1-8. doi: 10.1016/j.pedn.2018.05.008. Epub 2018 May 24.
2
Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.在新加坡,18-26 岁年轻女性中接种人乳头瘤病毒疫苗的促进因素和障碍:一项定性研究。
Vaccine. 2019 Sep 24;37(41):6030-6038. doi: 10.1016/j.vaccine.2019.08.053. Epub 2019 Aug 28.
3
Stakeholders' perspectives on system-level barriers to and facilitators of HPV vaccination among Hispanic migrant farmworkers.利益相关者对西班牙裔移民农场工人 HPV 疫苗接种的系统障碍和促进因素的看法。
Ethn Health. 2022 Aug;27(6):1442-1464. doi: 10.1080/13557858.2021.1887820. Epub 2021 Mar 18.
4
Impact of Virginia's School-Entry Vaccine Mandate on Human Papillomavirus Vaccination Among 13-17-Year-Old Females.弗吉尼亚州入学疫苗强制令对13至17岁女性人乳头瘤病毒疫苗接种的影响
J Womens Health (Larchmt). 2017 Mar;26(3):266-275. doi: 10.1089/jwh.2016.5869. Epub 2016 Oct 3.
5
The challenge of HPV vaccination uptake and opportunities for solutions: Lessons learned from Alabama.HPV 疫苗接种率面临的挑战及解决方案的机遇:来自阿拉巴马州的经验教训。
Prev Med. 2018 Aug;113:124-131. doi: 10.1016/j.ypmed.2018.05.021. Epub 2018 May 22.
6
Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia.人乳头瘤病毒(HPV)疫苗接种的促进因素和障碍:佐治亚州农村的一项定性研究。
BMC Cancer. 2024 May 15;24(1):592. doi: 10.1186/s12885-024-12351-1.
7
Implementation of HPV vaccination guidelines in a diverse population in Los Angeles: Results from an environmental scan of local HPV resources and needs.在洛杉矶多样化人群中实施人乳头瘤病毒(HPV)疫苗接种指南:对当地HPV资源与需求的环境扫描结果
Vaccine. 2017 Sep 5;35(37):4930-4935. doi: 10.1016/j.vaccine.2017.07.080. Epub 2017 Jul 31.
8
Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.在高风险社区中,服务提供者对 HPV 疫苗接种的障碍和促进因素的看法。
Vaccine. 2012 Jun 22;30(30):4511-6. doi: 10.1016/j.vaccine.2012.04.062. Epub 2012 May 3.
9
Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action.增加人乳头瘤病毒(HPV)疫苗接种率的障碍、促进因素及潜在策略:一项为指导行动而进行的全州评估
Papillomavirus Res. 2018 Jun;5:21-31. doi: 10.1016/j.pvr.2017.11.003. Epub 2017 Dec 7.
10
Key informant perspectives on overcoming HPV vaccination barriers in low-immunization NY counties.在免疫接种率低的纽约县克服 HPV 疫苗接种障碍的关键知情人观点。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2407666. doi: 10.1080/21645515.2024.2407666. Epub 2024 Oct 6.

引用本文的文献

1
State and territory immunization program activities and their association with human papillomavirus vaccine initiation in the United States of America: A multilevel approach.美国各州及领地的免疫规划活动及其与人类乳头瘤病毒疫苗接种起始的关联:一种多层次方法
PLOS Glob Public Health. 2024 Dec 31;4(12):e0002852. doi: 10.1371/journal.pgph.0002852. eCollection 2024.
2
Perceptions of a State-Level HPV Vaccine Mandate and Exemption Option in Rural Virginia: A Qualitative Study.弗吉尼亚州农村地区对人乳头瘤病毒(HPV)疫苗强制接种及豁免选项的认知:一项定性研究
Vaccines (Basel). 2024 Apr 10;12(4):401. doi: 10.3390/vaccines12040401.
3
Acceptability of HPV Vaccines: A Qualitative Systematic Review and Meta-Summary.人乳头瘤病毒疫苗的可接受性:一项定性系统评价与元总结
Vaccines (Basel). 2023 Sep 14;11(9):1486. doi: 10.3390/vaccines11091486.
4
Differences in stakeholder-reported barriers and implementation strategies between counties with high, middle, and low HPV vaccine initiation rates: a mixed methods study.高、中、低HPV疫苗接种率县之间利益相关者报告的障碍和实施策略的差异:一项混合方法研究。
Implement Sci Commun. 2022 Sep 6;3(1):95. doi: 10.1186/s43058-022-00341-y.
5
A Behavioral analysis of nurses' and pharmacists' role in addressing vaccine hesitancy: scoping review.护士和药剂师在解决疫苗犹豫问题中的作用的行为分析:范围综述。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4487-4504. doi: 10.1080/21645515.2021.1954444. Epub 2021 Aug 18.
6
Implementation of the human papillomavirus school-entry requirement in Puerto Rico: barriers and facilitators using the consolidated framework for implementation research.波多黎各实施人乳头瘤病毒入学要求:使用实施研究综合框架的障碍和促进因素。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4423-4432. doi: 10.1080/21645515.2021.1955609. Epub 2021 Aug 9.
7
HPV vaccine promotion: Snapshot of two health departments during the COVID-19 pandemic.HPV 疫苗推广:COVID-19 大流行期间两个卫生部门的情况快照。
Public Health Nurs. 2021 Sep;38(5):715-719. doi: 10.1111/phn.12900. Epub 2021 May 3.
8
Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns.亚利桑那州药剂师和实习药剂师的人乳头瘤病毒疫苗接种行为和影响。
Hum Vaccin Immunother. 2021 Sep 2;17(9):3090-3095. doi: 10.1080/21645515.2021.1905469. Epub 2021 Apr 22.
9
Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review.9 至 26 岁人群人乳头瘤病毒疫苗接种的障碍和促进因素:系统评价。
Sex Transm Dis. 2021 Dec 1;48(12):e255-e262. doi: 10.1097/OLQ.0000000000001407.
10
Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy.了解基层医疗医生对于推荐人乳头瘤病毒(HPV)疫苗接种以及解决疫苗犹豫问题的看法。
Hum Vaccin Immunother. 2021 Jul 3;17(7):1961-1967. doi: 10.1080/21645515.2020.1854603. Epub 2021 Jan 13.

本文引用的文献

1
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.2016年美国13至17岁青少年的全国、地区、州及部分局部地区疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874-882. doi: 10.15585/mmwr.mm6633a2.
2
Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy.美国与人类乳头瘤病毒(HPV)疫苗相关的立法活动(2006 - 2015年):基于证据制定政策的必要性。
Risk Manag Healthc Policy. 2017 Mar 13;10:29-32. doi: 10.2147/RMHP.S128247. eCollection 2017.
3
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.2014年美国13至17岁青少年的全国、地区、州及部分局部地区疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2015 Jul 31;64(29):784-92. doi: 10.15585/mmwr.mm6429a3.
4
Physician Communication Training and Parental Vaccine Hesitancy: A Randomized Trial.医生沟通培训与家长的疫苗犹豫:一项随机试验。
Pediatrics. 2015 Jul;136(1):70-9. doi: 10.1542/peds.2014-3199. Epub 2015 Jun 1.
5
Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices.应对疫苗犹豫:商业和社会营销原则及实践的潜在价值。
Vaccine. 2015 Aug 14;33(34):4204-11. doi: 10.1016/j.vaccine.2015.04.039. Epub 2015 Apr 18.
6
Strategies for addressing vaccine hesitancy - A systematic review.应对疫苗犹豫的策略——一项系统综述
Vaccine. 2015 Aug 14;33(34):4180-90. doi: 10.1016/j.vaccine.2015.04.040. Epub 2015 Apr 18.
7
Should we do battle with antivaccination activists?我们应该与反疫苗活动人士作斗争吗?
Public Health Res Pract. 2015 Mar 30;25(2):e2521515. doi: 10.17061/phrp2521515.
8
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.九价人乳头瘤病毒(HPV)疫苗的使用:免疫实践咨询委员会的HPV疫苗接种最新建议
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4.
9
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.2007 - 2013年美国青少年人乳头瘤病毒疫苗接种覆盖率及2006 - 2014年疫苗上市后安全性监测
MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4.
10
Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis.高收入国家年轻女性人乳头瘤病毒疫苗接种的障碍与促进因素:一项定性系统评价与证据综合分析
BMC Public Health. 2014 Jul 9;14:700. doi: 10.1186/1471-2458-14-700.